Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Trial ID or NCT#
NCT00482352
Status
NOT RECRUITING
Purpose
This clinical trial is studying risk-group classification of patients with newly diagnosed acute lymphoblastic leukemia. Developing a risk-group classification guide may help doctors assign patients with newly diagnosed acute lymphoblastic leukemia to treatment clinical trials.
Official Title
Classification Of Acute Lymphoblastic Leukemia
Eligibility Criteria
Ages Eligible for Study: 1 Year to 30 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Exclusion Criteria:
Investigator(s)
Neyssa Marina
Contact us to find out if this trial is right for you.
Contact
Peds Hem/Onc CRAs
650-723-5535
View on ClinicalTrials.gov
